Search bioRxiv⌕ Search

Biology subjects

Dmitrieva, J.

Publications and source records attributed to Dmitrieva, J..

3 recordsLinked to original sources

BfBio: a graph-based tool for the prediction of Angiogenic Stalk Cell genes using a Personalized PageRank algorithm

Although most human protein coding genes have functional annotations in databases, such as GeneCards, many remain poorly characterized. To address this gap, computational tools can be leveraged to predict the functional roles of under-annotated genes by extracting patterns from complex biological networks. Here we introduce Brain-for-Biotech (BfBio), a framework designed to identify genes important for vascular endothelial cells (EC), which are crucial cells for vessel formation (angiogenesis), vascular homeostasis, hemostasis and blood/tissue barrier function but also critical mediators of immunity and cancer progression. BfBio utilizes a Personalized PageRank (PPR) algorithm on an integrated network of different omics datasets and publicly available gene-gene/protein-protein interaction databases. In this study, we apply the predictive capabilities of BfBio to infer angiogenic stalk cell phenotype function in genes for which this function was not known before. By leveraging a set of genes characterizing the stalk cell cluster in lung tumor EC models previously identified, we have achieved a high Area Under Receiver Operative Characteristic (AUC-ROC) performance (0.837). Enrichment analysis, coupled with a text mining application, further confirmed that among the 49 predicted genes four of them were poorly characterized yet possessed biologically relevant properties and were linked to cancer, thereby validating BfBio as a robust tool for prioritizing novel therapeutic targets in vascular biology.

cancer biology↗

Unraveling the polygenic architecture of complex traits using blood eQTL meta-analysis

SummaryWhile many disease-associated variants have been identified through genome-wide association studies, their downstream molecular consequences remain unclear.\n\nTo identify these effects, we performed cis- and trans-expression quantitative trait locus (eQTL) analysis in blood from 31,684 individuals through the eQTLGen Consortium.\n\nWe observed that cis-eQTLs can be detected for 88% of the studied genes, but that they have a different genetic architecture compared to disease-associated variants, limiting our ability to use cis-eQTLs to pinpoint causal genes within susceptibility loci.\n\nIn contrast, trans-eQTLs (detected for 37% of 10,317 studied trait-associated variants) were more informative. Multiple unlinked variants, associated to the same complex trait, often converged on trans-genes that are known to play central roles in disease etiology.\n\nWe observed the same when ascertaining the effect of polygenic scores calculated for 1,263 genome-wide association study (GWAS) traits. Expression levels of 13% of the studied genes correlated with polygenic scores, and many resulting genes are known to drive these traits.

genomics↗

Defining the genetic control of human blood plasma N-glycome using genome-wide association study

Glycosylation is a common post-translational modification of proteins. It is known, that glycans are directly involved in the pathophysiology of every major disease. Defining genetic factors altering glycosylation may provide a basis for novel approaches to diagnostic and pharmaceutical applications. Here, we report a genome-wide association study of the human blood plasma N-glycome composition in up to 3811 people. We discovered and replicated twelve loci. This allowed us to demonstrate a clear overlap in genetic control between total plasma and IgG glycosylation. Majority of loci contained genes that encode enzymes directly involved in glycosylation (FUT3/FUT6, FUT8, B3GAT1, ST6GAL1, B4GALT1, ST3GAL4, MGAT3, and MGAT5). We, however, also found loci that are likely to reflect other, more complex, aspects of plasma glycosylation process. Functional genomic annotation suggested the role of DERL3, which potentially highlights the role of glycoprotein degradation pathway, and such transcription factor as IKZF1.

genetics↗